article thumbnail

InMed Pharmaceuticals Announces Completed Enrollment in Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects

Puff Puff Post

SOURCE InMed Pharmaceuticals Inc. INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases. InMed Pharmaceuticals is exploring the therapeutic potential of CBN in diseases with high unmet medical needs.

article thumbnail

InMed Pharmaceuticals Announces Completed Enrollment in Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects

Puff Puff Post

SOURCE InMed Pharmaceuticals Inc. INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases. InMed Pharmaceuticals is exploring the therapeutic potential of CBN in diseases with high unmet medical needs.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Unlocking the Potential of CBD: Exploring The Benefits of CBD in Medical Marijuana

MMJ Recs

From oils and tinctures to capsules and topical creams, CBD is available in various forms to suit individual preferences and needs. Furthermore, ongoing clinical trials are investigating CBD’s efficacy in treating conditions such as multiple sclerosis, Parkinson’s disease, and substance abuse disorders.

CBD 52
article thumbnail

‘The most meaningful cannabis reform in decades’: Experts weigh in on new DEA rules

The Cannigma

‘Junk’ cannabis ‘ill-suited for clinical trials’. The cannabis grown at the University of Mississippi “is junk, ill-suited for clinical trials, and genetically closer to hemp than the marijuana available from dispensaries and used by Americans nationwide,” according to the lawsuit. Shutterstock).

DEA 133
article thumbnail

Ketamine One Advances Research Capabilities via Controlled Substance Dealers Licence Application

Cannabis Law Report

The Company and Its Subsidiary KGK Science Have Also Completed the Pre-Qualification Audits of Its Canadian Facilities to Enable Clinical Trials in an Arrangement with Aleafia Health. The audits will enable KGK to conduct clinical trials in the areas of psychedelics and nutraceuticals, among other substances of study.

article thumbnail

Dispatches from Wonderland Miami

Canna Law Blog

This is a topic we have covered regularly on the Canna Law Blog, most recently by Mason Marks , here. Pharmaceutical start-ups are betting on the treatment potential of psychedelics. The conference’s opening panel was on pathways to federal legalization.

article thumbnail

DMT Therapy: Coming to a Clinic Near You?

Canna Law Blog

In fact, Small Pharma has been conducting trials as reported by the BBC and expanded its clinical trial this past summer. Several months ago, Canada-based Algernon Pharmaceuticals submitted a request to U.S. regulators to launch a clinical program to study the use of DMT for the treatment of stroke-related dysfunction.

Therapy 88